Andreessen Horowitz June 28, 2022
Jennifer Doudna won the 2020 Nobel Prize in Chemistry for her co-discovery of CRISPR/Cas9, a versatile genome editing platform. In the decade since its discovery the toolbox of CRISPR technologies has exploded, acting like rocket fuel for curiosity-driven science. It is also increasingly a foundational technology for many biotech companies.
In this conversation, Doudna chats with a16z general partner Vijay Pande. Previously, he was a Professor at Stanford University, where he directed the Biophysics department. During his time there he also founded the Folding@Home Project and Globavir Biosciences.
Pande and Doudna grapple with questions facing scientists at this inflection point. How do you recognize a discovery that will open further opportunities to engineer biology? What will happen as CRISPR...